story of the week
Risk of HBsAg Seroreversion After Corticosteroid Treatment in Patients With Previous Hepatitis B Virus Exposure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of Hepatitis B Surface Antigen Seroreversion After Corticosteroid Treatment in Patients With Previous Hepatitis B Virus Exposure
J. Hepatol. 2020 Jan 01;72(1)57-66, GL Wong, VW Wong, BW Yuen, YK Tse, TC Yip, HW Luk, GC Lui, HL ChanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.